4[4]Piua B,Abinvich A,Anai Z et al IUterine sarcoma in the south of lsra2el:study of 36casesl J Surg Oneol,2001,68(1):55.
5[5]Sagae S,Yamashita K,Ishioka S,et al.Preoperative diagnosisand treatment results in 106 patientswith uterine sarcoma in Hok2kaido.Japan[J].Oncology.2004,67(1):33-39.
二级参考文献46
1[1]Sutton GP,Blessing JA,Rosenshein N,et al.Phase Ⅱ trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).Am J Obstet Gynecol,1989,161(2:309-312
2[2]Sutton G,Blessing J,Barret RJ,et al.Phase Ⅱ trial of ifosfamide and mesna in leiomyosarcoma of the uterus:a Gynecologic Oncology Group study.Am J Obstet Gynecol,1992,166(2:556-559
3[3]Thigpen JT,Blessing JA,Beecham J,et al.Phase Ⅱ trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcoma:a Gynecologic Oncology Group study.J Clin Oncol,1991,9(11:1962-1966
4[4]Omura GA,Major FJ,Blessing JA,et al.A randomized study of adrimycin with or without dimethyl triazinoimidazole carboxamide in advanced uterine sarcomas.Cancer,1983,52(4):626-632
5[5]Miller DS,Blessing JA,Kilgore LC,et al.Phase Ⅱ trial of topotecan in patients with advanced,persistent,or recurrent uterine leiomyosarcoma:a Gynecologic Oncology Group study.Am J Clin Oncol,2000,23(4):355-357
6[6]Curtin JP,Blessing JA,Soper JT,et al.Paclitaxel in the treatment of carcinosarcoma of the uterus:a Gynecologic Oncology Group study.Gynecol Oncol,2001,83(2:268-270
7[7]Gallup DG,Blessing JA,Andersen W,et al.Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus:a Gynecologic Oncology Group study.Gynecol Oncol,2003,89(1:48-51
8[8]Okuno S,Edmonson J,Mahoney M,et al.Phase Ⅱ trial of Gemcitabine in advanced sarcomas.Cancer,2002,94(12:3225-3229
9[9]Hensley ML,Maki R,Venkatraman E,et al.Gemcitabine and docetaxel in patients with unresected leiomyosarcoma:results of a phase Ⅱ trial.J Clin Oncol,2002,20(12:2824-2831
